Brainsway EBITDA Margin 2018-2024 | BWAY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Brainsway (BWAY) over the last 10 years. The current EBITDA margin for Brainsway as of December 31, 2024 is .
| Brainsway EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $0.04B | $0.00B | 7.32% |
| 2024-09-30 | $0.04B | $0.00B | 7.69% |
| 2024-06-30 | $0.04B | $0.00B | 5.56% |
| 2024-03-31 | $0.03B | 0 | 0.00% |
| 2023-12-31 | $0.03B | $0.00B | -9.38% |
| 2023-09-30 | $0.03B | $-0.01B | -27.59% |
| 2023-06-30 | $0.03B | $-0.01B | -46.15% |
| 2023-03-31 | $0.03B | $-0.01B | -50.00% |
| 2022-12-31 | $0.03B | $-0.01B | -40.74% |
| 2022-09-30 | $0.03B | $-0.01B | -27.59% |
| 2022-06-30 | $0.03B | $-0.01B | -15.63% |
| 2022-03-31 | $0.03B | $0.00B | -12.90% |
| 2021-12-31 | $0.03B | $0.00B | -10.34% |
| 2021-09-30 | $0.03B | $0.00B | -10.71% |
| 2021-06-30 | $0.03B | $0.00B | -7.69% |
| 2021-03-31 | $0.02B | $0.00B | -4.17% |
| 2020-12-31 | $0.02B | $0.00B | -18.18% |
| 2020-09-30 | $0.02B | $0.00B | -19.05% |
| 2020-06-30 | $0.02B | $-0.01B | -23.81% |
| 2020-03-31 | $0.02B | $-0.01B | -31.82% |
| 2019-12-31 | $0.02B | $-0.01B | -21.74% |
| 2019-09-30 | $0.02B | $-0.01B | -27.27% |
| 2019-06-30 | $0.02B | $-0.01B | -30.00% |
| 2019-03-31 | $0.02B | $-0.01B | -27.78% |
| 2018-12-31 | $0.02B | $-0.01B | -29.41% |
| 2018-06-30 | $0.01B | $0.00B | -27.27% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.166B | $0.041B |
| BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. BrainsWay Ltd. is based in Jerusalem, Israel. | |||